Cargando…

Pancreatic Ductal Adenocarcinoma: Preclinical in vitro and ex vivo Models

Pancreatic ductal adenocarcinoma (PDAC) is one of the most overlooked cancers despite its dismal median survival time of 6 months. The biggest challenges in improving patient survival are late diagnosis due to lack of diagnostic markers, and limited treatment options due to almost complete therapy r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gündel, Beate, Liu, Xinyuan, Löhr, Matthias, Heuchel, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569794/
https://www.ncbi.nlm.nih.gov/pubmed/34746135
http://dx.doi.org/10.3389/fcell.2021.741162

Ejemplares similares